相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design and synthesis of thiourea based receptor containing naphthalene as oxalate selective sensor
Nongnit Morakot et al.
JOURNAL OF MOLECULAR MODELING (2010)
Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome
A. Villavicencio et al.
GYNECOLOGIC ONCOLOGY (2009)
Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology
Eddy Karnieli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
Mojca Jensterle et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia
K. Bacallao et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
The role of FoxO in the regulation of metabolism
D. N. Gross et al.
ONCOGENE (2008)
The FoxO transcription factors and metabolic regulation
Jun Nakae et al.
FEBS LETTERS (2008)
Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex
Ouliana Ziouzenkova et al.
FEBS LETTERS (2008)
PPARγ agonists -: Antidiabetic drugs with a potential role in the treatment of diseases other than diabetes
Gyorgy Jermendy
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome
Richard S. Legro et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1
Sachie Asada et al.
CELLULAR SIGNALLING (2007)
Transcriptional regulation of the GLUT4 gene: from PPAR-gamma and FOXO1 to FFA and inflammation
Michal Armoni et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome
C. Avellaira et al.
HUMAN REPRODUCTION (2006)
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
Ricardo Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
FOXO1 represses peroxisome proliferator-activated receptor-γ1 and -γ2 gene promoters in primary adipocytes -: A novel paradigm to increase insulin sensitivity
Michal Armoni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Peroxisome proliferator-activated receptor γ and growth inhibition by its ligands in uterine endometrial carcinoma
Kyoko Ota et al.
CLINICAL CANCER RESEARCH (2006)
Molecular mechanisms of insulin resistance in polycystic ovary syndrome
Evanthia Diamanti-Kandarakis et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Endometrium in PCOS: Implantation and predisposition to endocrine CA
Linda C. Giudice
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition
P. Froment et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome
S Quezada et al.
FERTILITY AND STERILITY (2006)
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome
DA Ehrmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Direct thiazolidinedione action in the human ovary: Insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production
D Seto-Young et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1
L Al-Khalili et al.
DIABETOLOGIA (2005)
Evidence-based care of recurrent miscarriage
TF Porter et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2005)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients
R Mioni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome
M Maliqueo et al.
FERTILITY AND STERILITY (2003)
Peroxisome proliferator-activated receptor-γ represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect
M Armoni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of beta-cell dysfunction?
M Maliqueo et al.
HUMAN REPRODUCTION (2003)
Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis
A Castro et al.
FERTILITY AND STERILITY (2002)
Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone
NA Cataldo et al.
FERTILITY AND STERILITY (2001)
Association of insulin, resistance with hyperandrogenia in women
M Pugeat et al.
HORMONE RESEARCH (2000)
分享论文
